VOLUME 5 (2014)
Table of Contents
Editorial
|
| Metastatic cells: moving oncotargets |
|
https://doi.org/10.18632/oncotarget.2057
|
| 3424-3425 |
|
| Targeting FANCD2 for therapy sensitization |
|
https://doi.org/10.18632/oncotarget.2070
|
| 3426-3427 |
Reviews
|
| Expression and functionality of histone H2A variants in cancer |
|
https://doi.org/10.18632/oncotarget.2007
|
| 3428-3443 |
Research Papers
|
| Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.1813
|
| 3444-3454 |
|
| Elevated Orai1 expression mediates tumorpromoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1903
|
| 3455-3471 |
|
| Epigenetic silencing of the noncoding RNA nc886 provokes oncogenes during human esophageal tumorigenesis |
|
https://doi.org/10.18632/oncotarget.1927
|
| 3472-3481 |
|
| The role of S100A14 in epithelial ovarian tumors |
|
https://doi.org/10.18632/oncotarget.1947
|
| 3482-3496 |
|
| Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture |
|
https://doi.org/10.18632/oncotarget.1950
|
| 3497-3511 |
|
| MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR152 and DNA methyltransferase 1 |
|
https://doi.org/10.18632/oncotarget.1953
|
| 3512-3525 |
|
| Acrolein and 4AminobiphenylDNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells |
|
https://doi.org/10.18632/oncotarget.1954
|
| 3526-3540 |
|
| Caveolin1 regulates lung cancer stemlike cell induction and p53 inactivation in carbon nanotubedriven tumorigenesis |
|
https://doi.org/10.18632/oncotarget.1956
|
| 3541-3554 |
|
| DNA damage modulates interactions between microRNAs and the 26S proteasome |
|
https://doi.org/10.18632/oncotarget.1957
|
| 3555-3567 |
|
| JG6 a novel marinederived oligosaccharide suppresses breast cancer metastasis via binding to cofilin |
|
https://doi.org/10.18632/oncotarget.1959
|
| 3568-3578 |
|
| Decitabine reactivated pathways in platinum resistant ovarian cancer |
|
https://doi.org/10.18632/oncotarget.1961
|
| 3579-3589 |
|
| HER2signaling pathway JNK and ERKs kinases and cancer stemlike cells are targets of Bozepinib |
|
https://doi.org/10.18632/oncotarget.1962
|
| 3590-3606 |
|
| BRAF V600E mutations in urine and plasma cellfree DNA from patients with ErdheimChester disease |
|
https://doi.org/10.18632/oncotarget.1964
|
| 3607-3610 |
|
| The tumor suppressive role of CAMK2N1 in castrationresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.1968
|
| 3611-3621 |
|
| The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy |
|
https://doi.org/10.18632/oncotarget.1969
|
| 3622-3635 |
|
| Sox9 mediates Notch1induced mesenchymal features in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.1970
|
| 3636-3650 |
|
| Methaneseleninic acid and γTocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model |
|
https://doi.org/10.18632/oncotarget.1979
|
| 3651-3661 |
|
| Targeting Phosphatidylinositide3Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.1978
|
| 3662-3672 |
|
| β1 4Nacetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells |
|
https://doi.org/10.18632/oncotarget.1981
|
| 3673-3684 |
|
| Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL1 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.1986
|
| 3685-3696 |
|
| Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy |
|
https://doi.org/10.18632/oncotarget.1984
|
| 3697-3710 |
|
| Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPARdegrading enzyme |
|
https://doi.org/10.18632/oncotarget.1987
|
| 3711-3727 |
|
| Usp7 protects genomic stability by regulating Bub3 |
|
https://doi.org/10.18632/oncotarget.1989
|
| 3728-3742 |
|
| Blocking the formation of radiation–induced breast cancer stem cells |
|
https://doi.org/10.18632/oncotarget.1992
|
| 3743-3755 |
|
| MACC1 promotes carcinogenesis of colorectal cancer via βcatenin signaling pathway |
|
https://doi.org/10.18632/oncotarget.1993
|
| 3756-3769 |
|
| Loss of EGFR signalingregulated miR203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance |
|
https://doi.org/10.18632/oncotarget.1994
|
| 3770-3784 |
|
| Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.1997
|
| 3785-3799 |
|
| CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through downregulating miR519d |
|
https://doi.org/10.18632/oncotarget.1998
|
| 3800-3812 |
|
| Brachyury regulates proliferation of cancer cells via a p27Kip1dependent pathway |
|
https://doi.org/10.18632/oncotarget.1999
|
| 3813-3822 |
|
| Novel peptides suppress VEGFR3 activity and antagonize VEGFR3mediated oncogenic effects |
|
https://doi.org/10.18632/oncotarget.1709
|
| 3823-3835 |
|
| A virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.1657
|
| 3836-3848 |
|
| Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a ChemicalInduced animal model |
|
https://doi.org/10.18632/oncotarget.2000
|
| 3849-3861 |
|
| Sequential activation of Elk1/Egr1/GADD45α by arsenic |
|
https://doi.org/10.18632/oncotarget.1995
|
| 3862-3870 |
|
| Characteristics and survival of patients with advanced cancer and p53 mutations |
|
https://doi.org/10.18632/oncotarget.2004
|
| 3871-3879 |
|
| Snail regulates Nanog status during the epithelial–mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.2006
|
| 3880-3894 |
|
| The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib |
|
https://doi.org/10.18632/oncotarget.2019
|
| 3895-3906 |
|
| Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus |
|
https://doi.org/10.18632/oncotarget.2028
|
| 3907-3918 |
|
| The localization of HER4 intracellular domain and expression of its alternatelyspliced isoforms have prognostic significance in ER+ HER2 breast cancer |
|
https://doi.org/10.18632/oncotarget.2002
|
| 3919-3930 |
|
| Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX2/PGE2 and MIG7 |
|
https://doi.org/10.18632/oncotarget.2040
|
| 3931-3943 |
|
| nc886 a noncoding RNA of antiproliferative role is suppressed by CpG DNA methylation in human gastric cancer |
|
https://doi.org/10.18632/oncotarget.2047
|
| 3944-3955 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
